I studied at l'Université Claude Bernard Lyon, France where I obtained my bachelor in physiology and subsequently did a Masters in Immunology & Cancer at the University of Lausanne, Switzerland. Today, I am a PhD student in the lab of Marie-Catherine Vozenin (UNIL-CHUV) and I aim to exploring the radio-immunological imprint of FLASH-RT in tumors and normal tissue.

Institutional responsibilities • Vice-director, Institute of Radiation Physics, Lausanne, Switzerland • Group Leader, Institute of Radiation Physics, Lausanne, Switzerland: • State appointed leader of a verification laboratory active in ionizing radiation measuring instruments (radiation protection, radiotherapy, nuclear medicine) • Leader of the designated national metrology institute for the unit of activity (Bq) • Leader of an state approved personal dosimetry service • State appointed manager of interlaboratory comparison in the field of gamma spectrometry, radionuclide calibrators, uncertainty evaluation, and radiotherapy • Radiometrology support for the University hospitals of Lausanne IRA’s radiometrology group and Claude Bailat, its leader for over 15 years, are well recognized by the radiometrology community as well as stake holders in nuclear medicine, radiotherapy, medical physics and radiation protection. This recognition was achieved thanks to the synergy of the primary and secondary calibration laboratory (Eichstelle I02 certified by the State) fostered by Claude Bailat. The group of radiometrology has provided various research, support and consulting services to the ionizing radiation community. This synergy between radiometrology various fields is a unique asset for the university hospital of Lausanne, and IRA has developed the knowledge and equipment required of a top radiometrology institute. The group of radiometrology at IRA aims at reaching a high level of metrology and promotes the use of the scientific method.

I trained as a Therapeutic Radiographer at Kingston & St. George’s University of London in 2011 and commenced working at The Royal Preston Hospital in 2014. I worked in pre-treatment and treatment radiotherapy prior to commencing a role as a Proton Senior Radiographer in 2018 at The Christie NHS Foundation Trust in Manchester, before the proton service became clinical. I gained invaluable experience working in a new proton service, such as developing quality documents, ProBeam applications training and end to end testing. Myself and my colleague treated the first NHS proton patient in the UK in December 2018 and managed public proton enquiries with the governance team. My proton experience also includes proton pre-treatment expertise in mould room, CT and MR-Sim. I have a strong passion for learning and research. In 2021, I completed my MSc in radiotherapy and oncology and commenced a year secondment in radiotherapy research, which involved managing radiotherapy patients’ pathways through clinical trials and working clinically on the MR-Linac. I am often involved in teaching through The Christie Summer School and The Christie Proton School. I look forward to meeting you at the FRPT 2022 conference.

In Mexico, Paola Ballesteros-Zebadúa obtained her Master's degree in Medical Physics at the Institute of Physics of the UNAM receiving the Alfonso Caso Medal for Merit. Later she obtained honors for her Ph. D. in Biomedical Sciences at the Faculty of Medicine of the UNAM. Thanks to a grant from the Mexican National Council of Science, she started radiobiology research at the National Institute of Neurology and Neurosurgery to investigate the undesired late effects of radiotherapy in the CNS. Her laboratory was the first in Mexico dedicated to applied neurosciences focused on brain response after conventional radiotherapy. In parallel, she has worked on diverse neuroscience topics and dosimetry for small-animal irradiation. In Mexico, she organized and participated in several workshops for medical specialists and medical physics students about topics in radiobiology. She was a regular radiobiology lecturer at UNAM Mexico. She has also established close collaborations with other institutions and more recently with Prof. Vozenin at CHUV, Lausanne, Switzerland, and Prof. Limoli at UCI, Irvine, USA. In collaboration with them and with an SFNS grant she is now focused on exploring the feasibility of FLASH-RT as medulloblastoma treatment using orthotopic cerebellar injections of MB human cells in juvenile mice.

Lara Barazzuol obtained her PhD in 2012 at the University of Surrey followed by a postdoc at the Genome Damage and Stability Centre, University of Sussex in the UK. During this period, Lara developed a keen interest in the DNA damage response of the developing and adult brain. In 2016, Lara moved to the University Medical Center Groningen (UMCG), in the Netherlands, to establish her own group within the Departments of Radiation Oncology and Biomedical Sciences of Cells & Systems. Lara Barazzuol’s research focuses on assessing the effect of cancer treatment, primarily radiotherapy, on the brain. Her group is also interested in investigating how defects in DNA repair impact on human health, with a particular focus on neurodegenerative diseases. Highlights from her career include several young investigator awards, including the 2015 British Institute of Radiology Nic McNally Award, the 2017 Adrian Begg Award and the 2017 Bas Mulder Award. She is currently project leader and/or partner in KWF (Dutch Cancer Society), CRUK and SU2C funded grants.

Marco Battestini is a PhD student at University of Trento, working on FLASH radiotherapy in the Bio-Medical Radiation physics (BiMeR) research group, between the Trento Institute for Fundamental Physics and Applications (TIFPA), a research center of the National Institute for Nuclear Physics (INFN), the University of Trento and the Trento Proton Therapy Center, with an international collaboration with GSI (Helmholtz Center for Heavy Ions Research). In particular, he is focusing on understanding and optimization of physical parameters dependence for FLASH proton therapy scanning. He got the bachelor’s degree in physics at University of Trento in 2018. He achieved the master's degree in physics at University of Trento in 2021, with a thesis on including volume effects in treatment plan optimization for particle therapy.